Fundamentals data is not available for this company.
Year Ending | Revenue ($m) | Pre-tax ($m) | EPS | P/E | PEG | EPS Grth. | Div | Yield |
---|---|---|---|---|---|---|---|---|
31-Dec-25 | 40.64 | (587.39) | (602.58)¢ | n/a | n/a | n/a | n/a | 0.0% |
31-Dec-26 | 161.06 | (417.66) | (431.36)¢ | n/a | n/a | n/a | n/a | 0.0% |
31-Dec-27 | 368.09 | (333.12) | (342.61)¢ | n/a | n/a | n/a | n/a | 0.0% |
Copyright © 2025 FactSet Research Systems Inc. All rights reserved.
MaxCyte signs cell platform deal with CRISPR and... | 14-Mar-2017 | ShareCast |
Currency | US Dollars |
Share Price | $ 52.61 |
Change Today | $ -0.46 |
% Change | -0.87 % |
52 Week High | $68.14 |
52 Week Low | $32.38 |
Volume | 708,286 |
Shares Issued | 47.19m |
Market Cap | $2,482.82m |
RiskGrade | 311 |
Strong Buy | 6 |
Buy | 10 |
Neutral | 11 |
Sell | 2 |
Strong Sell | 0 |
Total | 29 |
Time | Volume / Share Price |
14:33 | 100 @ $52.61 |
14:33 | 100 @ $52.61 |
14:33 | 100 @ $52.61 |
14:33 | 100 @ $52.61 |
14:31 | 100 @ $52.62 |
You are here: research